What is HistoGenetics?
HistoGenetics is a specialized provider of advanced genetic testing services, encompassing critical areas such as HLA typing, whole genome sequencing, and comprehensive genomic analyses. The company's innovative technologies are instrumental in supporting donor registries, advancing pharmacogenomics, assisting transplant centers, and empowering HLA laboratories. By delivering high-quality and cost-effective solutions, HistoGenetics is dedicated to enhancing precision medicine through state-of-the-art sequencing methods and a full spectrum of tissue-typing services. Their target clientele includes healthcare providers, research institutions, and organizations focused on transplantation and immunogenetics.
How much funding has HistoGenetics raised?
HistoGenetics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for HistoGenetics?
The recent major strategic investment positions HistoGenetics for accelerated growth and further innovation in the precision medicine landscape. This influx of capital is expected to fuel the expansion of their service offerings, enhance their technological infrastructure, and broaden their market reach. The company's focus on critical areas like HLA typing and whole genome sequencing, coupled with their commitment to cost-effectiveness, suggests a strategic push to capture a larger share of the growing genetic diagnostics market. Future developments may include strategic partnerships, further research into novel sequencing applications, and the scaling of their operations to meet increasing demand from healthcare and research sectors.
See full HistoGenetics company page
